BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7723373)

  • 1. Family with nonmedullary thyroid neoplasms.
    Kobayashi K; Tanaka Y; Ishiguro S; Mori T; Mitani Y; Shigemasa C
    J Surg Oncol; 1995 Apr; 58(4):274-7. PubMed ID: 7723373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic analyses of three papillary carcinomas and a follicular adenoma of the thyroid.
    Olah E; Balogh E; Bojan F; Juhasz F; Stenszky V; Farid NR
    Cancer Genet Cytogenet; 1990 Jan; 44(1):119-29. PubMed ID: 2293877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Familial occurrence of papillary thyroid carcinoma].
    Suzuki S; Watanabe I
    Gan No Rinsho; 1985 Apr; 31(4):414-9. PubMed ID: 4009973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperfunctioning thyroid adenoma concomitant with papillary thyroid carcinoma, follicular thyroid adenoma and primary hyperparathyroidism.
    Sato Y; Sakurai A; Miyamoto T; Hiramatsu K; Katai M; Furihata K; Hashizume K
    Endocr J; 1998 Feb; 45(1):61-7. PubMed ID: 9625447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation and inactivation of Tob contributes to the progression of papillary carcinoma of the thyroid.
    Ito Y; Suzuki T; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Yamamoto T; Miyauchi A
    Cancer Lett; 2005 Apr; 220(2):237-42. PubMed ID: 15766599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial occurrence of papillary thyroid carcinoma.
    Lote K; Andersen K; Nordal E; Brennhovd IO
    Cancer; 1980 Sep; 46(5):1291-7. PubMed ID: 7214311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment.
    Takami H; Ozaki O; Ito K
    Arch Surg; 1996 Jun; 131(6):676. PubMed ID: 8645080
    [No Abstract]   [Full Text] [Related]  

  • 9. Morphological aspects of thyroid cancer and tumour prognosis.
    Williams D
    J Endocrinol Invest; 1995 Feb; 18(2):153-4. PubMed ID: 7629386
    [No Abstract]   [Full Text] [Related]  

  • 10. Noninvasive Follicular Thyroid Neoplasms With Papillary-like Nuclear Features Are Genetically and Biologically Similar to Adenomatous Nodules and Distinct From Papillary Thyroid Carcinomas With Extensive Follicular Growth.
    Johnson DN; Furtado LV; Long BC; Zhen CJ; Wurst M; Mujacic I; Kadri S; Segal JP; Antic T; Cipriani NA
    Arch Pathol Lab Med; 2018 Jul; 142(7):838-850. PubMed ID: 29582677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of glypican 3 in thyroid cancer.
    Yamanaka K; Ito Y; Okuyama N; Noda K; Matsumoto H; Yoshida H; Miyauchi A; Capurro M; Filmus J; Miyoshi E
    Oncology; 2007; 73(5-6):389-94. PubMed ID: 18511877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial papillary thyroid carcinoma].
    Ishimori M; Funaguchi N; Isaji M; Nakamura S
    Nihon Naika Gakkai Zasshi; 2002 Jan; 91(1):464-6. PubMed ID: 11925961
    [No Abstract]   [Full Text] [Related]  

  • 13. Familial nonmedullary thyroid carcinoma.
    Malchoff CD; Malchoff DM
    Semin Surg Oncol; 1999; 16(1):16-8. PubMed ID: 9890735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological behavior and prognosis of familial papillary thyroid carcinoma.
    Ito Y; Kakudo K; Hirokawa M; Fukushima M; Yabuta T; Tomoda C; Inoue H; Kihara M; Higashiyama T; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
    Surgery; 2009 Jan; 145(1):100-5. PubMed ID: 19081481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas.
    Stolf BS; Carvalho AF; Martins WK; Runza FB; Brun M; Hirata R; Jordão Neves E; Soares FA; Postigo-Dias J; Kowalski LP; Reis LF
    Cancer Lett; 2003 Mar; 191(2):193-202. PubMed ID: 12618333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
    Pyo JS; Kim DH; Yang J
    Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor receptor-2 expression in thyroid tumor progression: potential diagnostic application.
    Redler A; Di Rocco G; Giannotti D; Frezzotti F; Bernieri MG; Ceccarelli S; D'Amici S; Vescarelli E; Mitterhofer AP; Angeloni A; Marchese C
    PLoS One; 2013; 8(8):e72224. PubMed ID: 23977259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial nonmedullary thyroid neoplasia.
    Rubén Harach H
    Endocr Pathol; 2001; 12(2):97-112. PubMed ID: 11579685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial occurrence of differentiated, nonmedullary thyroid carcinoma.
    Ozaki O; Ito K; Kobayashi K; Suzuki A; Manabe Y; Hosoda Y
    World J Surg; 1988 Aug; 12(4):565-71. PubMed ID: 3048001
    [No Abstract]   [Full Text] [Related]  

  • 20. RET/PTC fusion gene rearrangements in Japanese thyroid carcinomas.
    Nibu K; Otsuki N; Nakao K; Sugasawa M; Rothstein JL
    Eur Arch Otorhinolaryngol; 2005 May; 262(5):368-73. PubMed ID: 15368067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.